Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department

NCT04281030
completednot_applicable

RELAXaHEAD for Headache Patients (Phase II)

NCT05466682
completednot_applicable

RELAXaHEAD for Headache Patients (Phase I)

NCT03183791

Clinical Trials (3)

Showing 3 of 3 trials
NCT04281030Not Applicable

Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department

Completed
NCT05466682Not Applicable

RELAXaHEAD for Headache Patients (Phase II)

Completed
NCT03183791Not Applicable

RELAXaHEAD for Headache Patients (Phase I)

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3